<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01876563</url>
  </required_header>
  <id_info>
    <org_study_id>17112</org_study_id>
    <nct_id>NCT01876563</nct_id>
  </id_info>
  <brief_title>the Effect of Vitamin D on the Serum Thioredoxin, TBP-2, Thioredoxin Reductase, Gene Expression of TBP-2 in Patients With Type II Diabetes</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is the comparision between the effects of vitamin D or placebo
      supplementation for 2 months in serum level of thioredoxin, TBP-2 and thioredoxin reductase
      activity in patients with type 2 diabetes
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum total cholesterol</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum HDL cholesterol</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum triglycerides level</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting plasma glucose</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum LDL cholesterol</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>complete blood count (CBC)</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum insulin</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum calcidiol</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>thioredoxin</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>thioredoxin binding protein 2 (TBP-2)</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>erytrocyte thioredoxin reductase</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>GENE EXPRESSION OF TBP-2</measure>
    <time_frame>change from baseline at 2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>diabetes, vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients with type 2 diabetes who receive 4000 IU/day vitamin D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo, diabetes</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients with type 2 diabetes who receive one tab placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D</intervention_name>
    <description>one tab 4000 IU/day vitamin D</description>
    <arm_group_label>diabetes, vitamin D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>one tab per day placebo</description>
    <arm_group_label>placebo, diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        literate, willingness to participation, diabetic patients 30- 60 years old, body mass index
        in the range 18.5- 35, avoidance of dietary supplements, vitamins and herbal products at
        least 3 months before and throughout the intervention -

        Exclusion Criteria:

        people who have used vitamin D supplements in last 3 months, having chronic renal disease ,
        GI disease, Hepatobilliary diseases, hematological disorders, hypo- or hyperthyroidism,
        treatment with orlistat or sibutramine for weight loss, pregnancy and lactation, treatment
        with insulin or Thiazolidinediones, Smokers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tehran University of Medical Sciences</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2013</study_first_submitted>
  <study_first_submitted_qc>June 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2013</study_first_posted>
  <last_update_submitted>June 10, 2013</last_update_submitted>
  <last_update_submitted_qc>June 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thioredoxin</keyword>
  <keyword>TBP-2</keyword>
  <keyword>thioredoxin reductase</keyword>
  <keyword>vitamin D</keyword>
  <keyword>DIABETES</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

